AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21282194
Drug: Schedule of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schedule of injections at days 0 and 6 months
Trial: 19058584
Drug: Oral penicillin
RxNorm normalized name: penicillin G Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral penicillin (500 mg bid)
Trial: 12663340
Drug: 10 parts
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 parts per million (ppm) inhaled nitric oxide (NO)
Trial: 11002377
Drug: 2.5 g
RxNorm normalized name: Vaporizer 2.5 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 g plant stanols at lunch
Trial: 11002377
Drug: 2.5 g
RxNorm normalized name: Vaporizer 2.5 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 g plant stanols divided over three meals (0.42 g at breakfast, 0.84 g at lunch, 1.25 g at dinner)
Trial: 11002377
Drug: 2.5 g
RxNorm normalized name: Vaporizer 2.5 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 g plant stanols divided over three meals
Trial: 9296243
Drug: Zafirlukast (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zafirlukast (oral administration)
Trial: 9296243
Drug: Zafirlukast (aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zafirlukast (aerosol dosing)
Trial: 27733396
Drug: FeSO4 (∼8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FeSO4 (∼8 mg Fe)
Trial: 27733396
Drug: NaFeEDTA (∼8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaFeEDTA (∼8 mg Fe, ∼41 mg EDTA)
Trial: 27733396
Drug: Na2EDTA (∼41
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Na2EDTA (∼41 mg EDTA)
Trial: 12797340
Drug: Budesonide 128
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide 128 g/day
Trial: 10836006
Drug: Multimodal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal treatment for noncomplicated colon and rectal cancer
Trial: 10836006
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy for colon adenocarcinoma and rectal cancer
Trial: 10836006
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment for complicated colorectal cancer
Trial: 31795035
Drug: Escitalopram or
RxNorm normalized name: escitalopram Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram or Sertraline (females only)
Trial: 25099201
Drug: Dose reduction
RxNorm normalized name: Rebetron Combination Package for Rebetol Dose Reduction, Intron A 6,000,000 UNT/ML Multi-Dose Vial / 42 Rebetol Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose reduction of risperidone or olanzapine (dose reduced by 50%)
Trial: 17488138
Drug: Community pharmacist-led
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community pharmacist-led medicines management service
Trial: 15258006
Drug: Dronabinol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronabinol (10 mg daily)
Trial: 11236522
Drug: Haemodialysis for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haemodialysis for 2-3 hours, started as early as possible after administration of CM (106 +/- 25 minutes)
Trial: 30536713
Drug: Continued treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued treatment after 3 years of zoledronic acid
Trial: 24188204
Drug: Budesonide 100
RxNorm normalized name: budesonide 100 MCG/ACTUAT Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 100 μg plus oral procaterol 25 μg
Trial: 24188204
Drug: Budesonide 100
RxNorm normalized name: budesonide 100 MCG/ACTUAT Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 100 μg plus placebo
Trial: 11293640
Drug: Erythromycin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (250 mg, four times daily for 10 days)
Trial: 11293640
Drug: Co-amoxiclav (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-amoxiclav (325 mg, four times daily for 10 days)
Trial: 30783649
Drug: All antiretroviral
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All antiretroviral drugs
Trial: 25940060
Drug: Radial shock
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radial shock wave therapy plus plantar fascia-specific stretching (Group 2, n = 79)
Trial: 25940060
Drug: Radial shock
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radial shock wave therapy alone (Group 1, n = 73)
Trial: 22030569
Drug: Subcutaneous injections
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injections with retractable fixed syringes and needles
Trial: 22030569
Drug: Subcutaneous injections
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injections with no needles combined
Trial: 22030569
Drug: Intramuscular injections
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injections with retractable fixed syringes and needles
Trial: 22030569
Drug: Intramuscular injections
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injections with no needles combined
Trial: 17614027
Drug: Running with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Running with ingestion of a 4 % glucose solution (GLU)
Trial: 16941885
Drug: Low intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intensity laser treatment
Trial: 14550821
Drug: 0.75 mg
RxNorm normalized name: propinox 0.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mg everolimus twice daily
Trial: 14550821
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg everolimus twice daily
Trial: 8823459
Drug: 100 IU
RxNorm normalized name: Vitamin E 100 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 IU per kg of rHuEPO subcutaneously twice a week for 2 weeks
Trial: 1389934
Drug: Amitriptyline (10-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (10-50 mg a day)
Trial: 1389934
Drug: Oral oxycodone
RxNorm normalized name: oxycodone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oxycodone (0.28 mg kg-1)
Trial: 1389934
Drug: Intramuscular oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular oxycodone (0.14 mg kg-1)
Trial: 22327097
Drug: Computerised cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computerised cognitive behaviour therapy (CCBT)
Trial: 16108749
Drug: Caudal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal block with bupivacaine 1 mL/kg after anesthetic induction
Trial: 16108749
Drug: Diclofenac suppository
RxNorm normalized name: diclofenac Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac suppository 3 mg/kg postinduction and local anesthetic infiltration at port sites
Trial: 11167952
Drug: 200 microg
RxNorm normalized name: Digoxin 200 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg intranasal mometasone furoate (MF) once daily
Trial: 11167952
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral montelukast plus 10 mg oral cetirizine once daily (MON/CZ)
Trial: 9552083
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (HRT + etidronate)
Trial: 9552083
Drug: HRT, etidronate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT, etidronate, combined therapy
Trial: 2845694
Drug: Edrophonium 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium 0.5 mg/kg
Trial: 2845694
Drug: Neostigmine 0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 0.04 mg/kg
Trial: 29426304
Drug: modified directly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: modified directly observed therapy
Trial: 29426304
Drug: group treatment
RxNorm normalized name: Allergenic Extracts Intradermal Kit [9 SO. GRASS GROUP TREATMENT SET]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: group treatment
Trial: 29426304
Drug: self‐administered individual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: self‐administered individual treatment (control)
Trial: 25082830
Drug: Novel nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Novel nicotine inhaler device (0.45 mg and 0.67 mg)
Trial: 25082830
Drug: Nicorette® Inhalator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorette® Inhalator (10 mg)
Trial: 24277401
Drug: Clean liquid
RxNorm normalized name: ALCOHOL 70 mL in 100 mL TOPICAL LIQUID [ServClean Liquid Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clean liquid integral protein diet for 3 days before operation without mechanical bowel preparation
Trial: 24277401
Drug: Traditional diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional diet and mechanical bowel preparation
Trial: 21515531
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy recommendation for patients with type 1 diabetes
Trial: 21515531
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy recommendation for patients with type 2 diabetes
Trial: 21515531
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy recommendation for patients with schizophrenia
Trial: 21515531
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy recommendation for patients with epilepsy
Trial: 21515531
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy recommendation for retired patients
Trial: 21515531
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy recommendation for unemployed patients
Trial: 17690160
Drug: 1170 CC
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1170 CC genotype
Trial: 14727937
Drug: roxifiban (DMP754)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxifiban (DMP754) 2 mg/day
Trial: 14727937
Drug: roxifiban (DMP754)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxifiban (DMP754) 2.5 mg/day
Trial: 1362305
Drug: Flunitrazepam (Rohypnol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam (Rohypnol tabl. 1 mg), Tramadol (Tramal caps. 50 mg), Metipranolol (Trimepranol tabl. 10 mg)
Trial: 1362305
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of drugs with Metipranolol
Trial: 22398821
Drug: 70 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 μg/kg ephedrine
Trial: 22398821
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg lidocaine
Trial: 22398821
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml NaCl 0.9% (placebo)
Trial: 17604880
Drug: Extended dosing
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended dosing schedule (0, 10, 13, 32 weeks)
Trial: 17604880
Drug: Regular dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular dosing schedule (0, 3, 6, 32 weeks)
Trial: 1967666
Drug: Mitozantrone 14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitozantrone 14 mg/m2 intravenously every 3 weeks for 9 weeks
Trial: 1967666
Drug: Continue chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continue chemotherapy
Trial: 1967666
Drug: Stop chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stop chemotherapy
Trial: 28177908
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg/d and Ezetimibe 10 mg/d
Trial: 19730304
Drug: 0.2% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% lidocaine administered through the vacuum-assisted closure tubing into the foam dressing 30 minutes before dressing change
Trial: 19730304
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline administered through the vacuum-assisted closure tubing into the foam dressing 30 minutes before dressing change
Trial: 12472837
Drug: Placebo (scaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (scaled groups without mechanical treatment)
Trial: 2475697
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of anipamil
Trial: 2475697
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg of anipamil
Trial: 2475697
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg of anipamil
Trial: 781233
Drug: Fenoprofen (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoprofen (200 mg to 600 mg every six hours)
Trial: 781233
Drug: Aspirin (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (325 mg to 975 mg every six hours)
Trial: 26143615
Drug: Aluminum-adjuvanted trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum-adjuvanted trivalent PPrV (50 μg per antigen)
Trial: 26143615
Drug: Aluminum-adjuvanted trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum-adjuvanted trivalent PPrV (10 μg)
Trial: 26143615
Drug: Aluminum-adjuvanted trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum-adjuvanted trivalent PPrV (25 μg)
Trial: 26143615
Drug: Aluminum-adjuvanted trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum-adjuvanted trivalent PPrV (50 μg)
Trial: 23300160
Drug: Trivalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent inactivated influenza vaccine (TIV) plus 7-valent pneumococcal vaccine (PCV7)
Trial: 23300160
Drug: Trivalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent inactivated influenza vaccine (TIV) alone
Trial: 23300160
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal vaccine (PCV7) alone
Trial: 6804625
Drug: CO2 inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CO2 inhalation
Trial: 19602608
Drug: Glucose-based solutions
RxNorm normalized name: glucose Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-based solutions (GLU)
Trial: 17879825
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens (CEE) at doses of 0.3, 0.625, and 1.25 mg for 3 months each, totaling 9 months of treatment.
Trial: 14693584
Drug: bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine plus 1 micro g/kg clonidine
Trial: 14693584
Drug: bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine plus 2 micro g/kg clonidine
Trial: 14693584
Drug: bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine plus 0.25, 0.5 micro g/kg clonidine
Trial: 12359987
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with nitrendipine (with second- and third-line enalapril and hydrochlorothiazide)
Trial: 31152874
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy with anti-arrhythmic drugs
Trial: 25319932
Drug: Poly-L-lactic acid
RxNorm normalized name: POLY-L-LACTIC ACID
DrugBank: Poly(lactic acid) (DB15037)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Poly-L-lactic acid (PLA) filler
Trial: 19349547
Drug: Vitamin D(3)
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D(3) (cholecalciferol) 400 IU and calcium carbonate 1,000 mg daily for 1 year
Trial: 31095602
Drug: MRCI-K (Korean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRCI-K (Korean version of the medication regimen complexity index)
Trial: 25951857
Drug: Tofacitinib 2
RxNorm normalized name: tofacitinib 22 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 2 mg, 5 mg, or 15 mg, twice daily for 12 weeks
Trial: 17373900
Drug: Trastuzumab (humanised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab (humanised monoclonal antibody to the HER2 receptor)
Trial: 17373900
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and endocrine therapies
Trial: 15292325
Drug: Risedronate 5
RxNorm normalized name: risedronate 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 5 mg daily for nine months
Trial: 9034949
Drug: Self‐administered, structured,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self‐administered, structured, previsit questionnaire combined with a postvisit questionnaire
Trial: 9034949
Drug: Interviewer‐administered, semistructured,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interviewer‐administered, semistructured, previsit interview combined with a postvisit questionnaire
Trial: 31328432
Drug: Assisted reproductive
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assisted reproductive technologies (ART) and non-IVF fertility treatments (NIFTs)
Trial: 27999970
Drug: Oral 30%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 30% glucose solution (2 ml/3 kg doses)
Trial: 27999970
Drug: Intravenous midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous midazolam (0.1 mg/kg with 0.05 mg/kg repetition)
Trial: 26356162
Drug: Cerebrolysin (intravenously
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin (intravenously in dose 20 ml in 100 ml of physiological solution, 5 days a week, during 4 weeks)
Trial: 20488830
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g glucose
Trial: 20488830
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g glucose
Trial: 16959149
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Group A)
Trial: 15040556
Drug: Combination therapies
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapies (AQ + SP, AR + SP, AQ + AR)
Trial: 8585876
Drug: Amtolmetineguacil 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amtolmetineguacil 600 mg by os twice daily for the first two days followed by 600 mg once daily for 19 days (Group A1)
Trial: 8585876
Drug: Amtolmetineguacil 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amtolmetineguacil 600 mg twice daily for 21 days (Group A2)
Trial: 8585876
Drug: diclofenac 50
RxNorm normalized name: DICLOFENAC 50MG/MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac 50 mg twice daily by os for 21 days (Group V)
Trial: 31076942
Drug: Concentrated fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concentrated fish oil in combination with evening primrose oil
Trial: 25524913
Drug: 10% Intralipid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% Intralipid at 100 mL/h
Trial: 17309405
Drug: Highly active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly active antiretroviral therapy (HAART) with at least three effective ARVs from at least two different drug classes
Trial: 17309405
Drug: Adherence to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherence to drug therapy greater than 95%
Trial: 17309405
Drug: Monotherapy, two-drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy, two-drug combinations, sequential ARVs, drug cycling, and treatment interruptions
Trial: 4009919
Drug: Concurrent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent infusion with 20% fat emulsion
Trial: 25980923
Drug: Intra-articular injection
RxNorm normalized name: PHOSPHORUS P-32 5 mCi in 1 mL INTRA-ARTICULAR INJECTION, SUSPENSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular injection of platelet-rich plasma (PRP)
Trial: 28878035
Drug: Standard regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard regimen (3 × 500 mg Ca/d)
Trial: 28878035
Drug: Low-dose regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose regimen (2 × 500 mg Ca/d)
Trial: 23398636
Drug: Standard diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard diet + 6 × 60 ml/day of Pro-Cal (60 ml = 200 kcal + 4 g protein)
Trial: 19845100
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream (lidocaine 2.5% plus prilocaine 2.5%) applied daily